In 2015, Cwerman-Thibault et al. [106] introduced a recombinant AAV2 containing ND4 into a rat model of LHON, demonstrating both the safety and efficacy of allotropic ND4 expression in treating LHON. Here, MT-ND4 is linked to Leber hereditary optic neuropathy.